Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 300,886,272
  • Shares Outstanding, K 1,765,868
  • Annual Sales, $ 54,318 M
  • Annual Income, $ 4,863 M
  • 60-Month Beta 0.60
  • Price/Sales 5.60
  • Price/Cash Flow 10.84
  • Price/Book 37.60
Trade ABBV with:

Options Overview Details

View History
  • Implied Volatility 18.67% ( -1.29%)
  • Historical Volatility 18.33%
  • IV Percentile 45%
  • IV Rank 22.31%
  • IV High 29.42% on 04/12/24
  • IV Low 15.58% on 09/01/23
  • Put/Call Vol Ratio 0.26
  • Today's Volume 19,424
  • Volume Avg (30-Day) 15,872
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 358,833
  • Open Int (30-Day) 339,743

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 3.06
  • Number of Estimates 11
  • High Estimate 3.11
  • Low Estimate 2.98
  • Prior Year 2.91
  • Growth Rate Est. (year over year) +5.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
153.58 +10.95%
on 05/30/24
173.01 -1.51%
on 06/18/24
+7.46 (+4.58%)
since 05/21/24
3-Month
153.58 +10.95%
on 05/30/24
182.30 -6.53%
on 03/28/24
-7.11 (-4.01%)
since 03/21/24
52-Week
130.96 +30.11%
on 06/28/23
182.89 -6.83%
on 03/12/24
+33.53 (+24.50%)
since 06/21/23

Most Recent Stories

More News
10 Stocks to Build a Dividend Portfolio That Will Pay You $1,000s per Year

The power of compounding can build huge amounts of passive income.

HD : 355.80 (+0.67%)
MS : 96.16 (-1.31%)
ABT : 105.72 (-0.80%)
UNH : 482.59 (-0.40%)
MA : 454.85 (+0.52%)
V : 275.22 (-0.58%)
NEE : 72.81 (+0.48%)
AVGO : 1,658.63 (-4.38%)
TXN : 195.53 (+1.44%)
ABBV : 170.39 (-1.01%)
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data

/CNW/ -- USA News Group – This year's 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without increasing...

ONCY : 1.0100 (+1.45%)
ABBV : 170.39 (-1.01%)
AZN : 78.88 (+0.41%)
PFE : 27.74 (unch)
BMY : 41.93 (+2.17%)
ONC.TO : 1.37 (+0.74%)
Key Takeaways from the 2024 ASCO Annual Meeting: Promising Developments in Cancer Care

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – This year’s 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not...

ONCY : 1.0100 (+1.45%)
ONC.TO : 1.37 (+0.74%)
ABBV : 170.39 (-1.01%)
AZN : 78.88 (+0.41%)
PFE : 27.74 (unch)
BMY : 41.93 (+2.17%)
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now

Don't sleep on the value of quality dividends.

MSFT : 449.78 (+0.92%)
NVDA : 126.57 (-3.22%)
ABBV : 170.39 (-1.01%)
SBUX : 79.91 (+0.24%)
2 Dividend Stocks That Could Pay You for Life

There are other reasons to love these businesses, too.

ABBV : 170.39 (-1.01%)
V : 275.22 (-0.58%)
2 High-Yield Dividend Stocks to Buy Right Now

These two high-yield dividend stocks are top buys right now.

ABBV : 170.39 (-1.01%)
PFE : 27.74 (unch)
Is Abbvie Stock Underperforming the S&P 500?

Despite headwinds from Humira patent expiry, potential price controls from the Inflation Reduction Act, and recent underperformance relative to the S&P 500, Wall Street analysts anticipate moderate gains...

ABBV : 170.39 (-1.01%)
AMGN : 308.16 (-0.56%)
$SPX : 5,464.62 (-0.16%)
Top Stocks to Buy in June

Here are a few high-quality stocks trading at intriguing valuations.

INTU : 632.15 (+2.61%)
ADBE : 533.44 (+2.01%)
ABBV : 170.39 (-1.01%)
3 Cathie Wood Biotech Stocks That Analysts Expect to Double

This article delves into three biotech stocks held in Cathie Wood's ARKK ETF that analysts expect to double in value. Investors looking to add exposure to promising biotech opportunities, with a preference...

ARKK : 43.32 (-0.12%)
NTLA : 24.22 (+0.29%)
PRME : 5.99 (-2.60%)
BEAM : 22.94 (-0.43%)
XBI : 92.38 (+2.77%)
WFC : 58.10 (-1.46%)
VKTX : 52.74 (+4.58%)
CRSP : 56.24 (-5.64%)
ABBV : 170.39 (-1.01%)
AMGN : 308.16 (-0.56%)
BMY : 41.93 (+2.17%)
GILD : 70.67 (+3.18%)
3 No-Brainer Stocks to Buy in June

Now is the time to invest in these great stocks.

ABBV : 170.39 (-1.01%)
AZN : 78.88 (+0.41%)
VRTX : 468.71 (-0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

AbbVie has become one of the top-most pharma companies after it acquired Allergan. The deal has transformed AbbVie's portfolio by lowering its dependence on Humira, its flagship product. AbbVie has one of the most popular cancer drugs in its portfolio, Imbruvica and its newest immunology drugs Skyrizi...

See More

Key Turning Points

3rd Resistance Point 175.69
2nd Resistance Point 174.31
1st Resistance Point 172.35
Last Price 170.39
1st Support Level 169.01
2nd Support Level 167.63
3rd Support Level 165.67

See More

52-Week High 182.89
Last Price 170.39
Fibonacci 61.8% 163.05
Fibonacci 50% 156.93
Fibonacci 38.2% 150.80
52-Week Low 130.96

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar